Invesco Ltd. Wave Life Sciences Ltd. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Invesco Ltd. holds 35,659 shares of WVE stock, worth $481,753. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,659

Previous 35,142 1.47%

Holding current value

$481,753

Previous $175,000 66.86%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.12 - $9.01 $2,647 - $4,658	517 Added 1.47%	35,659 $292,000
Q2 2024 Aug 13, 2024	SELL	$4.38 - $6.48 $38,767 - $57,354	-8,851 Reduced 20.12%	35,142 $175,000
Q1 2024 May 14, 2024	BUY	$3.54 - $6.84 $22,004 - $42,517	6,216 Added 16.45%	43,993 $271,000
Q4 2023 Feb 12, 2024	BUY	$4.16 - $6.87 $23,732 - $39,193	5,705 Added 17.79%	37,777 $190,000
Q3 2023 Nov 13, 2023	SELL	$3.56 - $5.75 $2,556 - $4,128	-718 Reduced 2.19%	32,072 $184,000
Q2 2023 Aug 11, 2023	BUY	$3.51 - $4.69 $115,092 - $153,785	32,790 New	32,790 $119,000
Q2 2022 Aug 15, 2022	SELL	$1.23 - $3.25 $20,584 - $54,388	-16,735 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.0 - $3.28 $3,390 - $5,559	1,695 Added 11.27%	16,735 $34,000
Q4 2021 Feb 14, 2022	SELL	$3.14 - $5.15 $1,604 - $2,631	-511 Reduced 3.29%	15,040 $47,000
Q3 2021 Nov 15, 2021	BUY	$4.89 - $7.12 $14,689 - $21,388	3,004 Added 23.94%	15,551 $76,000
Q2 2021 Aug 17, 2021	BUY	$5.65 - $7.47 $70,890 - $93,726	12,547 New	12,547 $84,000
Q2 2019 Aug 14, 2019	SELL	$22.93 - $42.84 $479,558 - $895,955	-20,914 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$32.69 - $47.91 $5.33 Million - $7.82 Million	-163,130 Reduced 88.64%	20,914 $813,000
Q4 2018 Feb 14, 2019	BUY	$37.1 - $50.11 $6.83 Million - $9.22 Million	184,044 New	184,044 $7.74 Million

Others Institutions Holding WVE

# of Institutions

164

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.17B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account